FDA issued a Warning Letter to Bristol Myers Squibb Holdings Pharma., Ltd. on 8/30/2010 for a later inspection.
483 Bristol-Myers Squibb Holdings Pharma Liability Company Mar 2003

483 Bristol-Myers Squibb Holdings Pharma Liability Company Mar 2003

Jorge Guadalupe FDA, Rebeca Melendez FDA$595.00 - Available Now

FDA investigators audited the Bristol-Myers Squibb Holdings Pharma Liability Company - Manati, PR, United States facility and issued inspectional observations (via FDA 483) on 13 Mar 2003.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Mar 2003
  • Location: Manati, United States
  • FEI: 2650089
Add To Cart